Boston Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Boston Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 43% to $9,336. The net income raised on -$907,883 and profit margin reached -9725%. Total operating expenses were $763,229.

Profit Margin

Boston Therapeutics, Inc. (OTC:BTHE): Profit margin
2012 42.25K -1.48M -3512.37%
2013 323.41K -4.60M -1422.8%
2014 199.58K -4.69M -2354.89%
2015 98.94K -2.48M -2516.46%
2016 98.87K -3.73M -3779.93%
2017 29.35K -1.58M -5398.8%
2018 31.72K -3.60M -11352.07%
2019 16.32K -3.69M -22622.81%
2020 9.33K -907.88K -9724.54%

BTHE Income Statement (2012 – 2020)

2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
9.33K16.32K31.72K29.35K98.87K98.94K199.58K323.41K42.25K
Cost of revenue
32.04K27.00K67.13K094.14K240.47K175.82K278.20K56.85K
Gross profit
-22.70K-10.67K-35.41K29.35K4.73K-141.52K23.75K45.20K-14.60K
Operating exp.
Research and development
180.90K1.71M182.66K177.64K83.84K352.78K1.43M542.49K178.93K
Selling and marketing
898791.23K77.16K23.90K111.56K31.26K320.35K329.21K232.41K
Total operating expenses
763.22K3.48M1.99M1.29M1.26M1.95M4.69M4.62M1.44M
Operating income
-785.93K-3.49M-2.03M-1.26M-1.26M-2.10M-4.67M-4.58M-1.46M
Other income (expenses), net
-121.94K-200.84K-1.56M-319.21K-2.46M-388.52K-25.59K-21.25K-21.59K
Income before tax
-907.88K-3.69M-3.60M-1.58M-3.73M-2.48M-4.69M-4.60M-1.48M
Income tax expense
308.09K141.67K-838.65K1.33M4.01K-223.74K-5.58K-1.56K0
Net income
-907.88K-3.69M-3.60M-1.58M-3.73M-2.48M-4.69M-4.60M-1.48M
Earnings per share
Basic EPS
-0.00-0.03-0.03-0.03-0.08-0.06-0.12-0.18-0.09
Diluted EPS
-0.00-0.03-0.03-0.03-0.08-0.06-0.12-0.18-0.09
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source